high risk

Showing 1 - 12 of 12

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer, Biochemical Recurrence, High Risk Trial in Nanjing, Nantong (Apalutamide 60mg Tab, Androgen deprivation

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Apalutamide 60mg Tab
  • Androgen deprivation therapy(ADT)
  • Nanjing, Jiangsu, China
  • +2 more
Mar 17, 2023

Prostate Cancer, High Risk Trial in Houston (68Ga-PSMA)

Active, not recruiting
  • Prostate Cancer
  • High Risk
  • Houston, Texas
    Houston Methodist
Dec 8, 2022

Elective Surgery, High Risk, Prevention of Surgical Site Infections Trial in Zürich (Whole Body and nasal decolonization with

Not yet recruiting
  • Elective Surgery
  • +3 more
  • Whole Body and nasal decolonization with octenidin (Octenisan Set)
  • Questionnaire for study participants immediately after the decolonization
  • Zürich, Zurich, Switzerland
    Balgrist University Hospital
Dec 9, 2022

Infection Cardiac, Heart Failure, Cardiac Implantable Electronic Device Infections Trial in Naples (Tauropace)

Recruiting
  • Infection Cardiac
  • +3 more
  • Tauropace
  • Naples, Italy
    Prof Antonio Rapacciuolo,MD, PhD
Nov 8, 2022

Diet, Healthy, High Risk Trial (Mediteranean to Western to Mediteranean Diet, Western to Mediteranean to Western Diet)

Not yet recruiting
  • Diet, Healthy
  • High Risk
  • Mediteranean to Western to Mediteranean Diet
  • Western to Mediteranean to Western Diet
  • (no location specified)
Oct 17, 2022

Asymptomatic, High Risk, Diabetes Trial in Belgrade (Echocardiography, CT angiography)

Recruiting
  • Asymptomatic
  • +2 more
  • Echocardiography
  • CT angiography
  • Belgrade, Serbia
    Clinical Centre of Serbia
Aug 11, 2021

Myeloma, Newly Diagnosed, High Risk Trial in GuangZhou (bortezomib, Lenalidomide, Dexamethasone)

Unknown status
  • Myeloma
  • +2 more
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 15, 2020

High Risk, Pregnancy Trial in Faisal (Fetal movement count)

Completed
  • High Risk
  • Pregnancy
  • Fetal movement count
  • Faisal, Giza, Egypt
    Rania Mahmoud Abdel Ghani
Sep 10, 2020

Autoantibody Positive, Non-diabetic Relatives at Risk for Type 1 Diabetes, High Risk Trial in Canada, Germany, United States

Completed
  • Autoantibody Positive
  • +3 more
  • San Francisco, California
  • +18 more
Jul 21, 2020

Hodgkin Lymphoma in First Complete Remission

Completed
  • Hodgkin Lymphoma
  • +2 more
  • Standard cohort: Clinical lab follow-up
  • Imaging cohort: integrated imaging follow-up
  • (no location specified)
Mar 4, 2020

High Risk, Breast Cancer, Positive Nodes Trial in New York (Doxorubicin, Cyclophosphamide, G-CSF)

Completed
  • High Risk
  • +4 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 24, 2017

T-cell Lymphoma Adults, Previously Untreated, High Risk Trial in GuangZhou (chemo (CHOP), chemo(c-ATT))

Unknown status
  • T-cell Lymphoma Adults
  • +2 more
  • GuangZhou, Guangdong, China
    Tumor center, Sun Yat-sen University
Dec 10, 2015